Zurueck zur Suche

Reporte zur Charge U028826

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

16Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 3 FL 2 PA 2 MD 2 ME 2 KY 1 NY 1 GA 1 IL 1 WI 1

VAERS 2403060

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

schwer
Staat
FL
Alter
11,0
Geschlecht
F
Eingang
05.08.2022
Impfdatum
03.08.2022
Beginn
04.08.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Aphasia Asthenia Blood glucose Cardiac monitoring Computerised tomogram head Dyspnoea Electrocardiogram Fall Full blood count Head injury Laboratory test Metabolic function test Neurological examination normal Seizure Tremor Troponin Tunnel vision Urine analysis

Symptomtext

35 hours post vaccination, pt sitting at kitchen table, after a nap, felt week and vision began to narrow and become black and tunnelled, pt could not get her words out then fell out of the chair, hitting her forehead on flood. hands and legs were shaking and pt felt like she couldn't breathe. total event time 5 minutes without loc. within 5 minutes of shaking stopping, EMS has arrived and pt was or normal cognitiion and awareness. pt was taken to ER for evaluation, and their eval was that pt has a seizure. Per my collection of hx of event, pt had no postictal period. pt was not prescribed any antiepileptics and was only given verbal precautions to follow regarding future seizures. Pt on exam today (18 hours a 18 hours post event) had completely nml exam including complete neuro exam. peds neurology referral ordered

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
Cardiac monitoring with continuou pulse oximetry, EKG, UA, UDS, Troponin 1-Quant, point of care blood glucose, CBC, CMP, Head CT w/o contrast
Aktuelle Erkrankungen
menses - first day of cycle was 07/31/2022
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2374878

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

schwer
Staat
PA
Alter
11,0
Geschlecht
F
Eingang
20.07.2022
Impfdatum
20.07.2022
Beginn
20.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Loss of consciousness Pallor Unresponsive to stimuli

Symptomtext

Clinic nurse administered vaccine and had patient wait in room, mother yelled out and that clinic nurse responded and then yelled out for a doctor as patient had passed out. Doctor and second nurse entered room, patient had been sitting a chair so no fall occurred. Patient was then awake but not responsive, vitals were taken and a Rapid response was called. Patient then came-to and asked what happened and had her sip on apple juice as she was pale. Rapid Response Team came and had her lay on the exam table. 15-20 mins later patient's color mostly returned and she felt well enough to walk out of the clinic when she was accompanied by a nurse.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
no
Vorgeschichte
Constipation
Andere Medikamente
no
Allergien
no
Vorherige Impfungen
-

VAERS 2490220

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

moderat
Staat
KY
Alter
16,0
Geschlecht
M
Eingang
26.10.2022
Impfdatum
26.10.2022
Beginn
26.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Blood pressure increased Chills Dizziness Headache Heart rate increased Rash macular Tremor

Symptomtext

Patient received vaccines in office and was fine when left and went on to school. Mom called the office one and a half hours later and stated that he was in the school nurse office shaking uncontrollably and dizzy. Told mom to bring him by the office and we would check him out. When child got to the office he was light headed, dizzy, had a headache, shaking uncontrollable, had a blotchy rash and rigor. Patients blood pressure and pulse was elevated. Provider came into office and evaluated patient. We kept him in office for about 30 minutes after coming back to clinic, Provider advised mom to take him to the emergency room to continue to be evaluated to make sure no other symptoms occur, mom was in agreeance.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
None in the clinic on 10/26/2022
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Cetirizine 10 mg, Singulair 10 mg
Allergien
None
Vorherige Impfungen
-

VAERS 2581507

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

mild
Staat
MD
Alter
11,0
Geschlecht
M
Eingang
14.02.2023
Impfdatum
09.02.2023
Beginn
10.02.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site swelling

Symptomtext

site on injection: right arm red, swollen , and tender to touch vaccines given on 2/9/23 around 2:30 mother called doctor office on 2/11/23 for symptoms around 9:00 a.m. mother noticed symptoms on 2/10/23 patient also received Tdap and Hep B but was given in left arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
nka
Vorherige Impfungen
-

VAERS 2405755

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

mild
Staat
PA
Alter
9,0
Geschlecht
M
Eingang
09.08.2022
Impfdatum
09.08.2022
Beginn
09.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness

Symptomtext

approximately 15 minutes after receiving both vaccines patient c/o dizziness. Pt was laid on exam table, feet were elevated. After approximately 5 minutes patient was able to drink a cup of water but still c/o dizziness. Blood pressure was taken and was normal. After approximately 10-15 minutes later patient stated he felt better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
intermittent asthma without complications
Andere Medikamente
albuterol inhaler, zyrtec, singulair
Allergien
peanut tree nuts
Vorherige Impfungen
-

VAERS 2404699

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

mild
Staat
ME
Alter
18,0
Geschlecht
M
Eingang
08.08.2022
Impfdatum
08.07.2022
Beginn
09.07.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain in extremity

Symptomtext

Patient c/o sore arm (no redness or swelling, no other reaction) lasting three weeks after injection. Note that his other vaccine was given in the opposite arm

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
sulfa
Vorherige Impfungen
-

VAERS 2401263

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

mild
Staat
NY
Alter
12,0
Geschlecht
M
Eingang
04.08.2022
Impfdatum
02.08.2022
Beginn
02.08.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia

Symptomtext

Mother called to report patient developed fever 101.1. Messages left by pediatric nurse to obtain more information..

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONW
Andere Medikamente
NONE
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2296494

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge U028826

mild
Staat
GA
Alter
33,0
Geschlecht
F
Eingang
26.05.2022
Impfdatum
20.05.2022
Beginn
20.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pruritus Rash Urticaria

Symptomtext

Received vaccine at 10am 5/20/22, toes began itching at 3pm same day. Broke out in rash/hives/itchiness thereafter. She took Benadryl and by am on 5/21/22 all had subsided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Had Covid 5/4/22
Vorgeschichte
Hidradenitis Suppurativa
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2233847

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

mild
Staat
FL
Alter
11,0
Geschlecht
M
Eingang
14.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Burning sensation Injection site nodule Injection site rash

Symptomtext

He had a burning sensation in his armpit afterwards for a couple days and a knot where it was administered in addition to a rash that is quarter size around the area.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site nodule
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
multi-vitamin
Allergien
none
Vorherige Impfungen
-

VAERS 2418261

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

gering
Staat
TX
Alter
16,0
Geschlecht
M
Eingang
23.08.2022
Impfdatum
17.08.2022
Beginn
17.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

Adult TD was in advertently given to wrong age group. Patient did not experience any adverse symptoms or reactions. Monitored the patient for 15 minutes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2404498

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U028826

gering
Staat
MD
Alter
18,0
Geschlecht
M
Eingang
08.08.2022
Impfdatum
02.08.2022
Beginn
02.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

After the patient left the clinic while completing the vaccination record paperwork, this RN realized the Bexero vaccine administered to the patient had an expiration date of 07/31/22. Supervisor was immediately notified. Call placed to Glaxo Smith-Kline Medical Information to find out vaccine viability period past the expiration date. Spoke to Medical Information Scientist who informed this RN that although GSK does not recommend, and the CDC has not evaluated the immunogenicity or safety of giving an expired vaccine, an in-house stability analysis and potency testing study shows that when stored under proper conditions and temperatures, the Bexero vaccine remains within approved specification up to 30 days past the expiration date. The Bexero Vaccine given had been continuously stored in the proper conditions and temperatures prior to being administered. This RN requested writtten documentation of information received over the telephone, and received the information via email. No adverse reactions were reoprted by the patient or parent.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2402285

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
05.08.2022
Impfdatum
27.07.2022
Beginn
27.07.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

no adverse event; a 4th dose of GARDASIL 9 was inadvertently administered to the patient; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 27-JUL-2022, the patient was inadvertently vaccinated with the 4th dose of 9-valent Human Papillomavirus (types 16, 18, 31, 33, 45, 52, 58, 6 and 11) recombinant vaccine (GARDASIL 9) 0.5 milliliter, lot#U028826, expiration date 04-NOV-2023 (route of administration was not reported) as prophylaxis (extra dose administered). No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2369079

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

gering
Staat
ME
Alter
18,0
Geschlecht
M
Eingang
14.07.2022
Impfdatum
24.05.2022
Beginn
24.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Patient received a sub-optimal COVID-19 vaccine due to a storage and handling error. Vaccine was stored in a regular freezer prior to being refrigerated and them administered. Requested that a VAERS form be submitted for this patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2341850

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

gering
Staat
TX
Alter
11,0
Geschlecht
M
Eingang
29.06.2022
Impfdatum
29.06.2022
Beginn
29.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

11 YEAR PATIENT GIVEN MMR WHEN MCV WAS ORDERED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2322669

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

gering
Staat
IL
Alter
1,0
Geschlecht
U
Eingang
17.06.2022
Impfdatum
13.06.2022
Beginn
13.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

No additional AE reported; A dose of GARDASIL 9 was inadvertently administered to a 1 year old patient.; This spontaneous report has been received from a nurse referring a 1 year-old patient. The patient's pertinent medical history, previous drugs reactions or allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) at a dose of 0.5 milliliter, lot number U028826, expiration date: 04-NOV-2023, as prophylaxis (vaccination scheme anatomical location and route of administration were not provided) (product administered to patient of inappropriate age). No additional adverse event was reported. The outcome of the event was not reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2284437

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U028826

gering
Staat
WI
Alter
-
Geschlecht
M
Eingang
19.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product No adverse event Product primary packaging issue Syringe issue

Symptomtext

No additional adverse events reported; Nurse reports that GARDASIL 9 was administered to a patient where product squirted in the Patient's face.; it was noticed that the administered GARDASIL 9 had a pin size hole located in the luer lock tip cap/Nurse found one more prefilled syringe with the same size hole and in the same location that was not administered.; apin size hole located in the luer lock tip cap; broken syringe barrel; cracked or broken luer lock; This spontaneous report was received from a registered nurse, referring to a male patient of unknown age. The patient's pertinent medical history, concomitant medications, previous drug reactions, or allergies were not reported. On 02-MAY-2022, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (strength, vaccination scheme, anatomical site of vaccination and route of administration were not reported; lot number U028826, expiration date reported and validated as 04-NOV-2023) as prophylaxis. On 02-MAY-2022, a hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was administered to a patient where product squirted in the patient's face (accidental exposure to product). Nurse reported that upon investigation, it was noticed that the administered hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) had a pin size hole located in the luer lock tip cap. Nurse reported that she investigated the rest of the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) and found one more prefilled syringe with the same size hole and in the same location that was not administered (syringe issue and product primary packaging issue). No additional adverse events reported. Nurse reporting a product quality complaint and adverse event pertaining to GARDASIL 9. Nurse reports that GARDASIL 9 was administered to a patient where product squirted in the Patient's face. Nurse reports that upon investigation, it was noticed that the administered GARDASIL 9 had a pin size hole located in the luer lock tip cap. Nurse reports that she investigated the rest of the GARDASIL 9 and found one more prefilled syringe with the same size hole and in the same location that was not administered. Nurse did not want to provide any Patient information. Nurse stated that Patient was okay and the Provider was going to take care of it in house. No additional adverse events reported. QUESTION SECTION: Medium Risk: Broken Syringe Barrel. High Risk: Cracked or Broken Luer Lock (Needle Attachment Issues), Broken Finger Flange. Notes for DPOC: A cracked syringe has a line or chip in the glass, but the syringe is essentially intact in one piece. A syringe is considered broken when the syringe is in 2 or more pieces. A syringe is also considered "cracked" if it appears to be intact with evidence of a chip or crack OR appears to be intact initially but then breaks into 2 or more pieces during use (such as while attaching a needle or injecting diluent). Please provide a detailed description of the defect using the questions below: Is there a crack? No o If yes, describe the size, shape & depth of the crack: o Provide the exact location of the crack on the syringe: Is the syringe broken into 2 or more pieces? No o If yes, describe in detail how it is broken: (e.g., shattered, broken in half etc.) o Provide the exact location of the breakage on the syringe? o Does the syringe have a broken component? No (e. g. broken syringe tip; loose or detached luer lock, or broken finger flange) o If yes describe in detail how it is broken. o Provide the exact location of the breakage on the syringe? o Is the tip of the syringe or Luer lock adaptor loose or broken off of the syringe tip? YES/NO/NA/ UNSPECIFIED (if yes describe). o Was there difficulty trying to attach the syringe needle to the syringe? No o If yes, describe o If yes, was it supplied by MERCK: YES/NO/NA/UNSPECIFIED. o If not supplied by MERCK, what type & brand, needle size & gauge was used? Under what situation was this defect noticed: (select one) 1: administered: 2: upon investigation of all products o While the syringe was still in the tray? Yes, #2 o If yes, is there product (liquid or dried residue) in the tray? No o Is there any broken glass or other separated component in the tray? (if yes specify) No o After removing the syringe from the tray? No While trying to attach the needle to the syringe? No o While giving the injection? Yes, #1 o Immediately after giving the injection? No Was the syringe tip cap attached properly prior to use? Yes o If no, describe issue: Was the syringe tray intact and undamaged on receipt? Yes o If no, describe damage. If the product came with a cellophane cover, was the cellophane covering the syringe tray intact and completely sealed? oSee below. Yes o If no, describe damage Was the syringe carton damaged prior to use? (i.e., crushed, ripped, unglued) No o If yes, describe Was the product administered or exposed to patient's bodily fluids (i.e., biohazardous)? Yes If complaint sample is not/cannot be returned, please provide reason: *If photos are available, ask the customer to send them Retrieval Information: Obtain product (& tray if possible) Expedite return for cracked syringes. If there is a doubt whether it is cracked or broken, please expedite. NOTE: Vaccine Prefilled Syringes may be returned even if biohazardous. Sample Tracking Number: User's Experience: Unknown Insertion Difficulty: Not Applicable Insertion Difficulty Details: Not Applicable Doubt About Presence: Doubt Details: Migration: Migration Details: Removal Problem: Removal Problem Details: 06-MAY-2022: Based on the review of the PQC the priority for this record has been changed per Product Quality Complaint, Complaint Category and Risk Priority Table. 06-may-2022: tip cap that was removed a photo of the syringe thank you. Notification; 1102160767 06-MAY-2022 14:30 PM: Email received in the PQC mailbox on 06-MAY-2022 at 1:09pm with the following request from quality: "Please clarify if the hole was in part of the tip cap that was removed or in the plastic Luer Lock piece that the needle is screwed onto. Please request a photo of the syringe and request the syringe that was not administered to be returned if available. " 09-MAY-2022 12:30 PM: Nurse reported that she looked up the parts of the syringe and stated that hole was in the luer lock location of syringe. Nurse reported that she will attempt to send pictures if possible due to how small the hole is. Agent provided Nurse with email address listed in PQC questionnaire to submit pictures. Nurse reports that she will return both syringes, the one that was administered, as well as, the non-administered syringe that she found in the box. No further details provided. 09-MAY-2022: Attached f/u: Email received in PQC mailbox on 05-MAY-2022 at 3:36pm from Quality: "Also please ask if the syringe that was administered is available for return in addition to the one that was not administered." Forwarded to case owner for follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-